Viorel Jinga

Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss

Johann S. de Bono, Ugo De Giorgi, Daniel Nava Rodrigues et al. · Clinical Cancer Research · 2018 · 310 citations

Medicine, Oncology, Pharmacology +15

A germline variant in the TP53 polyadenylation signal confers cancer susceptibility

Simon Stacey, Patrick Sulem, Áslaug Jónasdóttir et al. · Nature Genetics · 2011 · 304 citations · Full text

Medicine, Genetics, Molecular Genetics +12

Differences in Ureteroscopic Stone Treatment and Outcomes for Distal, Mid-, Proximal, or Multiple Ureteral Locations: The Clinical Research Office of the Endourological Society Ureteroscopy Global Study

Enrique Perez Castro, Palle Jørn Sloth Osther, Viorel Jinga et al. · European Urology · 2014 · 229 citations

Medicine, Surgery, Urology +15

Variation in genomic landscape of clear cell renal cell carcinoma across Europe

Ghislaine Scélo, Yasser Riazalhosseini, Liliana Greger et al. · Nature Communications · 2014 · 200 citations · Full text

Medicine, Genetics, Oncology +13

A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer

Patrick Sulem, Daníel F. Guðbjartsson, Gísli Másson et al. · Nature Genetics · 2012 · 189 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16